Cargando…
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
The inflammatory activity in cirrhosis is often pronounced and related to episodes of decompensation. Systemic markers of inflammation may contain prognostic information, and we investigated their possible correlation with admissions and mortality among patients with newly diagnosed liver cirrhosis....
Autores principales: | Mynster Kronborg, Thit, Webel, Henry, O’Connell, Malene Barfod, Danielsen, Karen Vagner, Hobolth, Lise, Møller, Søren, Jensen, Rasmus Tanderup, Bendtsen, Flemming, Hansen, Torben, Rasmussen, Simon, Juel, Helene Bæk, Kimer, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654496/ https://www.ncbi.nlm.nih.gov/pubmed/37973887 http://dx.doi.org/10.1038/s41598-023-47384-2 |
Ejemplares similares
-
Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study
por: Kronborg, Thit Mynster, et al.
Publicado: (2021) -
Nurse-assisted and multidisciplinary outpatient follow-up among patients with decompensated liver cirrhosis: A systematic review
por: O’Connell, Malene Barfod, et al.
Publicado: (2023) -
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial
por: Kronborg, Thit M., et al.
Publicado: (2023) -
Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity?
por: Nabilou, Puria, et al.
Publicado: (2022) -
The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial
por: Kimer, Nina, et al.
Publicado: (2022)